Literature DB >> 25584036

A new biological marker candidate in female reproductive system diseases: Matrix metalloproteinase with thrombospondin motifs (ADAMTS).

Kadir Demircan1, İsmail Cömertoğlu2, Sümeyya Akyol1, Beyza Nur Yiğitoğlu2, Esma Sarıkaya3.   

Abstract

Playing a key role in the pathophysiology of many diseases, A Disintegrin-like and Metalloproteinase with Thrombospondin type-1 motif (ADAMTS) proteinases have been attracted more attention in obstetrics and gynecology. First discovered in 1997, this zinc-dependent proteinase family has 19 members today. These enzymes, which are located in the extracellular matrix (ECM), have a lot of very important functions, like matrix formation and resorption, angiogenesis, ovulation, and coagulation. In addition, in the pathogenesis of cancer, inflammation, arthritis, and connective tissue diseases, ADAMTS proteinases have crucial roles. The purpose of this review is to collect previous studies about obstetrics and gynecology that are related to ADAMTS enzymes and discuss the subject in many aspects to give an idea to the investigators who are interested in the subject.

Entities:  

Keywords:  ADAMTS; biological marker; reproductive diseases

Year:  2014        PMID： 25584036      PMCID： PMC4285216          DOI： 10.5152/jtgga.2014.14206

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN： 1309-0380


  55 in total

1.  Epistasis between IGF2R and ADAMTS19 polymorphisms associates with premature ovarian failure.

Authors:  J-A Pyun; S Kim; D H Cha; K Kwack
Journal:  Hum Reprod       Date:  2013-09-07       Impact factor: 6.918

Review 2.  Ovulation: new factors that prepare the oocyte for fertilization.

Authors:  Joanne S Richards
Journal:  Mol Cell Endocrinol       Date:  2005-04-29       Impact factor: 4.102

3.  Gonadotropin-dependent regulation of bovine pituitary adenylate cyclase-activating polypeptide in ovarian follicles prior to ovulation.

Authors:  Khampoune Sayasith; Kristy A Brown; Jean Sirois
Journal:  Reproduction       Date:  2007-02       Impact factor: 3.906

4.  Genome-wide association study of bone mineral density in premenopausal European-American women and replication in African-American women.

Authors:  Daniel L Koller; Shoji Ichikawa; Dongbing Lai; Leah R Padgett; Kimberly F Doheny; Elizabeth Pugh; Justin Paschall; Siu L Hui; Howard J Edenberg; Xiaoling Xuei; Munro Peacock; Michael J Econs; Tatiana Foroud
Journal:  J Clin Endocrinol Metab       Date:  2010-02-17       Impact factor: 5.958

5.  Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor.

Authors:  Kari M H Doyle; Darryl L Russell; Venkataraman Sriraman; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2004-07-15

6.  Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles.

Authors:  D Boerboom; D L Russell; J S Richards; J Sirois
Journal:  J Mol Endocrinol       Date:  2003-12       Impact factor: 5.098

7.  ADAMTS-1/METH-1 and TIMP-3 expression in the primate corpus luteum: divergent patterns and stage-dependent regulation during the natural menstrual cycle.

Authors:  Kelly A Young; Barton Tumlinson; Richard L Stouffer
Journal:  Mol Hum Reprod       Date:  2004-06-18       Impact factor: 4.025

8.  Down-regulated expression of A disintegrin and metalloproteinase with thrombospondin-like repeats-1 by progesterone receptor antagonist is associated with impaired expansion of porcine cumulus-oocyte complexes.

Authors:  Masayuki Shimada; Masahide Nishibori; Yasuhisa Yamashita; Junya Ito; Takahide Mori; JoAnne S Richards
Journal:  Endocrinology       Date:  2004-07-01       Impact factor: 4.736

9.  ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome.

Authors:  Nathalie Dagoneau; Catherine Benoist-Lasselin; Céline Huber; Laurence Faivre; André Mégarbané; Abdulrahman Alswaid; Hélène Dollfus; Yves Alembik; Arnold Munnich; Laurence Legeai-Mallet; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2004-09-13       Impact factor: 11.025

10.  Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes.

Authors:  Marie Scully; Mari Thomas; Mary Underwood; Henry Watson; Katherine Langley; Raymond S Camilleri; Amanda Clark; Desmond Creagh; Rachel Rayment; Vickie Mcdonald; Ashok Roy; Gillian Evans; Siobhan McGuckin; Fionnuala Ni Ainle; Rhona Maclean; William Lester; Michael Nash; Rosemary Scott; Patrick O Brien
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113
View more
  5 in total

1.  Effect of insulin on the mRNA expression of procollagen N-proteinases in chondrosarcoma OUMS-27 cells.

Authors:  Sumeyya Akyol; Ismail Cömertoğlu; Ridvan Firat; Özlem Çakmak; Yunus Yukselten; Gönül Erden; Veli Ugurcu; Kadir Demircan
Journal:  Oncol Lett       Date:  2015-06-04       Impact factor: 2.967

2.  Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome.

Authors:  M Karakose; K Demircan; E Tutal; T Demirci; M S Arslan; M Sahin; H T Celik; F Kazanci; J Karakaya; E Cakal; T Delibasi
Journal:  J Endocrinol Invest       Date:  2016-05-04       Impact factor: 4.256

Review 3.  The role of ADAMTS genes in preeclampsia.

Authors:  İrem Eda Gökdemir; Özlem Evliyaoğlu; Buğra Çoşkun
Journal:  Turk J Obstet Gynecol       Date:  2016-09-15

Review 4.  Molecular Advances in Preeclampsia and HELLP Syndrome.

Authors:  Angeliki Gardikioti; Theodora-Maria Venou; Eleni Gavriilaki; Evangelia Vetsiou; Ioulia Mavrikou; Konstantinos Dinas; Angelos Daniilidis; Efthymia Vlachaki
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

5.  Extracellular Matrix Mimicking Nanofibrous Scaffolds Modified With Mesenchymal Stem Cell-Derived Extracellular Vesicles for Improved Vascularization.

Authors:  Dake Hao; Hila Shimshi Swindell; Lalithasri Ramasubramanian; Ruiwu Liu; Kit S Lam; Diana L Farmer; Aijun Wang
Journal:  Front Bioeng Biotechnol       Date:  2020-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.